Loading clinical trials...
Loading clinical trials...
The purpose of the study is to confirm how long (i.e., how many days) it takes to reach steady-state when testosterone undecanoate is administered twice daily.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Clarus Therapeutics, Inc.
NCT03721497 · Bariatric Surgery Candidate, Male Hypogonadism, and more
NCT01765179 · Male Hypogonadism
NCT01665599 · Adult Male Hypogonadism
NCT02081300 · Male Hypogonadism
NCT01228071 · Male Hypogonadism
Alabama Clinical Therapeutics
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions